Asia Pacific Nuclear Imaging Market - Growth, Trends And Forecasts (2016 - 2021)

  • ID: 3241360
  • Report
  • Region: Asia, Asia Pacific
  • 74 pages
  • Mordor Intelligence
1 of 3
The Asia Pacific nuclear imaging market is the fastest growing market. Nuclear medicine is the use of radioisotopes for the diagnosis of diseases. The two major types of Nuclear imaging used commonly are PET and SPECT. Till recently, SPECT imaging was the mainstream modality for nuclear medicine applications like nuclear cardiology procedures. However, the trend is soon going to change because of global shortage of molybdenum-99 isotope which is in turn will lead to shortage of Technetium-99, which is the daughter product of molybdenum. Hence, PET imaging products which include hybrid PET-CT scanners hold a potential market size in coming years. The cost associated with PET-CT service can be as high as $275,000 per year. PET market is expected to witness more growth compared to SPECT imaging as it provides higher resolution images and the lack of availability of technetium-99m is propelling industry to look for alternative diagnostic procedures.

Asia Pacific region has the highest populous countries like China and India, which in turn contribute to a large aging population. There is also higher disease incidence in this region increasing the demand for advanced technologies like nuclear imaging. There is a large investment on the healthcare setup and medical research making these facilities accessible. The per capita income is increasing in these countries making such technologies more affordable.

Market is segmented into two major segments SPECT (Technetium-99m (TC-99m), Thallium-201 (TL-201), Iodine (I-123) and others) and PET (Fluorine-18, Rubidium-82 (RB-82) and others). The Market is segmented based on application market into SPECT (cardiology, lymphoma, thyroid, neurology and others) and PET (oncology, cardiology, neurology and others),by geography market (China, India, Japan, Australia and other countries ).Major players in the market are Cardiarc Ltd., Digirad Corporation, Gamme Medica Inc., GE healthcare, Hologic Inc. etc.

Drivers:

Major factors for the growth of the market are increasing use of SPECT and PET analysis in radiopharmaceuticals, increased awareness of people for radiopharmaceuticals, and ready availability of radiopharmaceuticals. Novel applications such as Alzheimer’s and continually expanding oncology application segment also drive the market.

Constraints:

The short half- life of radioisotopes, high capital investment, regulatory guidelines and reimbursement issues are the constraints in this market.

What the report offers?

1) Market Definition for the specified topic along with identification of key drivers and restraints for the market.
2) Market analysis for the Asia Pacific Nuclear Market in Healthcare Industry, with region specific assessments and competition analysis on a global and regional scale.
3) Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
4) Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.
5) Identification and analysis of the Macro and Micro factors that affect the Asia Pacific Nuclear imaging Market in Healthcare Industry on both global and regional scale.
6) A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Introduction
1.1 Report Description
1.2 Markets Covered
1.3 Research Methodology

2. Executive Summary

3. Market Overview
3.1 Market Definition
3.2 Market Drivers
3.3 Market Restraints
3.4 Market Opportunities
3.5 Threat

4. Market Segmentation
4.1 Diagnostic Technologies
4.1.1 SPECT Radioisotopes
4.1.1.1 Technetium-99m (TC-99m)
4.1.1.2 Thallium-201 (TL-201)
4.1.1.3 Iodine (I-123)
4.1.1.4 Others
4.1.2 PET Radioisotopes
4.1.2.1 Fluorine-18
4.1.2.2 Rubidium-82 (RB-82)
4.1.2.3 Others
4.2 By Applications
4.2.1 SPECT
4.2.1.1 Cardiology
4.2.1.2 Lymphoma
4.2.1.3 Thyroid
4.2.1.4 Neurology
4.2.1.5 Others
4.2.2 PET
4.2.2.1 Oncology
4.2.2.2 Cardiology
4.2.2.3 Neurology
4.2.2.4 Others
4.3 By Geography
4.3.1 Asia Pacific
4.3.1.1 China
4.3.1.2 India
4.3.1.3 Japan
4.3.1.4 Australia
4.3.1.5 Others

5. Porters Five Force Analysis
5.1 Bargaining Power of suppliers
5.2 Bargaining power of buyers
5.3 Degree of competition
5.4 Threat of substitution
5.5 Threat of new entrants

6. Competitive Landscape
6.1 Mergers & Acquisitions
6.2 Agreements, Collaborations & Partnerships
6.3 New Product Launches
6.4 Recommendations to new market players

7. Company profiles
7.1 AGFA-GEVAERT N.V.
7.2 CARDIARC LTD
7.3 DIGIRAD CORPORATION
7.4 GAMMA MEDICA INC
7.5 GE HEALTHCARE
7.6 HOLOGIC INC.
7.7 MEDX INC
7.8 NAVISCAN INC
7.9 POSITRON CORPORATION
7.10 SEGAMI CORPORATION
7.11 SIEMENS HEALTHCARE

8. List of Tables
9. Asia Pacific Nuclear Imaging Market by Diagnostic technology ($millions) (2014-2020)
10. Asia Pacific Nuclear Imaging Market by SPECT radioisotopes ($millions) (2014-2020)
11. Asia Pacific Nuclear Imaging Market by Technetium ($millions) (2014-2020)
12. Asia Pacific Nuclear Imaging Market by Thallium ($millions) (2014-2020)
13. Asia Pacific Nuclear Imaging Market by Iodine ($millions) (2014-2020)
14. Asia Pacific Nuclear Imaging Market by other Types in SPECT ($millions) (2014-2020)
15. Asia Pacific Nuclear Imaging Market by PET radioisotopes ($millions) (2014-2020)
16. Asia Pacific Nuclear Imaging Market by Fluorine-18 ($millions) (2014-2020)
17. Asia Pacific Nuclear Imaging Market by Rubidium-82 ($millions) (2014-2020)
18. Asia Pacific Nuclear Imaging Market by Others ($millions) (2014-2020)
19. Asia Pacific Nuclear Imaging Market by Applications ($millions) (2014-2020)
20. Asia Pacific Nuclear Imaging Market by SPECT- Cardiology ($millions) (2014-2020)
21. Asia Pacific Nuclear Imaging Market by SPECT-Lymphoma ($millions) (2014-2020)
22. Asia Pacific Nuclear Imaging Market by SPECT- Thyroid ($millions) (2014-2020)
23. Asia Pacific Nuclear Imaging Market by SPECT-Neurology ($millions) (2014-2020)
24. Asia Pacific Nuclear Imaging Market by SPECT-Others ($millions) (2014-2020)
25. Asia Pacific Nuclear Imaging Market by PET-Oncology ($millions) (2014-2020)
26. Asia Pacific Nuclear Imaging Market by PET- Cardiology ($millions) (2014-2020)
27. Asia Pacific Nuclear Imaging Market by PET-Neurology ($millions) (2014-2020)
28. Asia Pacific Nuclear Imaging Market by PET-Others ($millions) (2014-2020)
29. Asia Pacific Nuclear Imaging Market by Countries ($millions) (2014-2020)
30. China Nuclear Imaging Market by Diagnostic technology ($millions) (2014-2020)
31. China Nuclear Imaging Market by SPECT radioisotopes ($millions) (2014-2020)
32. China Nuclear Imaging Market by Technetium ($millions) (2014-2020)
33. China Nuclear Imaging Market by Thallium ($millions) (2014-2020)
34. China Nuclear Imaging Market by Iodine ($millions) (2014-2020)
35. China Nuclear Imaging Market by other Types in SPECT ($millions) (2014-2020)
36. China Nuclear Imaging Market by PET radioisotopes ($millions) (2014-2020)
37. China Nuclear Imaging Market by Fluorine-18 ($millions) (2014-2020)
38. China Nuclear Imaging Market by Rubidium-82 ($millions) (2014-2020)
39. China Nuclear Imaging Market by Others ($millions) (2014-2020)
40. China Nuclear Imaging Market by Applications ($millions) (2014-2020)
41. China Nuclear Imaging Market by SPECT- Cardiology ($millions) (2014-2020)
42. China Nuclear Imaging Market by SPECT-Lymphoma ($millions) (2014-2020)
43. China Nuclear Imaging Market by SPECT- Thyroid ($millions) (2014-2020)
44. China Nuclear Imaging Market by SPECT-Neurology ($millions) (2014-2020)
45. China Nuclear Imaging Market by SPECT-Others ($millions) (2014-2020)
46. China Nuclear Imaging Market by PET-Oncology ($millions) (2014-2020)
47. China Nuclear Imaging Market by PET- Cardiology ($millions) (2014-2020)
48. China Nuclear Imaging Market by PET-Neurology ($millions) (2014-2020)
49. China Nuclear Imaging Market by PET-Others ($millions) (2014-2020)
50. China Nuclear Imaging Market by Countries ($millions) (2014-2020)
51. India Nuclear Imaging Market by Diagnostic technology ($millions) (2014-2020)
52. India Nuclear Imaging Market by SPECT radioisotopes ($millions) (2014-2020)
53. India Nuclear Imaging Market by Technetium ($millions) (2014-2020)
54. India Nuclear Imaging Market by Thallium ($millions) (2014-2020)
55. India Nuclear Imaging Market by Iodine ($millions) (2014-2020)
56. India Nuclear Imaging Market by other Types in SPECT ($millions) (2014-2020)
57. India Nuclear Imaging Market by PET radioisotopes ($millions) (2014-2020)
58. India Nuclear Imaging Market by Fluorine-18 ($millions) (2014-2020)
59. India Nuclear Imaging Market by Rubidium-82 ($millions) (2014-2020)
60. India Nuclear Imaging Market by Others ($millions) (2014-2020)
61. India Nuclear Imaging Market by Applications ($millions) (2014-2020)
62. India Nuclear Imaging Market by SPECT- Cardiology ($millions) (2014-2020)
63. India Nuclear Imaging Market by SPECT-Lymphoma ($millions) (2014-2020)
64. India Nuclear Imaging Market by SPECT- Thyroid ($millions) (2014-2020)
65. India Nuclear Imaging Market by SPECT-Neurology ($millions) (2014-2020)
66. India Nuclear Imaging Market by SPECT-Others ($millions) (2014-2020)
67. India Nuclear Imaging Market by PET-Oncology ($millions) (2014-2020)
68. India Nuclear Imaging Market by PET- Cardiology ($millions) (2014-2020)
69. India Nuclear Imaging Market by PET-Neurology ($millions) (2014-2020)
70. India Nuclear Imaging Market by PET-Others ($millions) (2014-2020)
71. India Nuclear Imaging Market by Countries ($millions) (2014-2020)
72. Japan Nuclear Imaging Market by Diagnostic technology ($millions) (2014-2020)
73. Japan Nuclear Imaging Market by SPECT radioisotopes ($millions) (2014-2020)
74. Japan Nuclear Imaging Market by Technetium ($millions) (2014-2020)
75. Japan Nuclear Imaging Market by Thallium ($millions) (2014-2020)
76. Japan Nuclear Imaging Market by Iodine ($millions) (2014-2020)
77. Japan Nuclear Imaging Market by other Types in SPECT ($millions) (2014-2020)
78. Japan Nuclear Imaging Market by PET radioisotopes ($millions) (2014-2020)
79. Japan Nuclear Imaging Market by Fluorine-18 ($millions) (2014-2020)
80. Japan Nuclear Imaging Market by Rubidium-82 ($millions) (2014-2020)
81. Japan Nuclear Imaging Market by Others ($millions) (2014-2020)
82. Japan Nuclear Imaging Market by Applications ($millions) (2014-2020)
83. Japan Nuclear Imaging Market by SPECT- Cardiology ($millions) (2014-2020)
84. Japan Nuclear Imaging Market by SPECT-Lymphoma ($millions) (2014-2020)
85. Japan Nuclear Imaging Market by SPECT- Thyroid ($millions) (2014-2020)
86. Japan Nuclear Imaging Market by SPECT-Neurology ($millions) (2014-2020)
87. Japan Nuclear Imaging Market by SPECT-Others ($millions) (2014-2020)
88. Japan Nuclear Imaging Market by PET-Oncology ($millions) (2014-2020)
89. Japan Nuclear Imaging Market by PET- Cardiology ($millions) (2014-2020)
90. Japan Nuclear Imaging Market by PET-Neurology ($millions) (2014-2020)
91. Japan Nuclear Imaging Market by PET-Others ($millions) (2014-2020)
92. Japan Nuclear Imaging Market by Countries ($millions) (2014-2020)
93. Australia Nuclear Imaging Market by Diagnostic technology ($millions) (2014-2020)
94. Australia Nuclear Imaging Market by SPECT radioisotopes ($millions) (2014-2020)
95. Australia Nuclear Imaging Market by Technetium ($millions) (2014-2020)
96. Australia Nuclear Imaging Market by Thallium ($millions) (2014-2020)
97. Australia Nuclear Imaging Market by Iodine ($millions) (2014-2020)
98. Australia Nuclear Imaging Market by other Types in SPECT ($millions) (2014-2020)
99. Australia Nuclear Imaging Market by PET radioisotopes ($millions) (2014-2020)
100. Australia Nuclear Imaging Market by Fluorine-18 ($millions) (2014-2020)
101. Australia Nuclear Imaging Market by Rubidium-82 ($millions) (2014-2020)
102. Australia Nuclear Imaging Market by Others ($millions) (2014-2020)
103. Australia Nuclear Imaging Market by Applications ($millions) (2014-2020)
104. Australia Nuclear Imaging Market by SPECT- Cardiology ($millions) (2014-2020)
105. Australia Nuclear Imaging Market by SPECT-Lymphoma ($millions) (2014-2020)
106. Australia Nuclear Imaging Market by SPECT- Thyroid ($millions) (2014-2020)
107. Australia Nuclear Imaging Market by SPECT-Neurology ($millions) (2014-2020)
108. Australia Nuclear Imaging Market by SPECT-Others ($millions) (2014-2020)
109. Australia Nuclear Imaging Market by PET-Oncology ($millions) (2014-2020)
110. Australia Nuclear Imaging Market by PET- Cardiology ($millions) (2014-2020)
111. Australia Nuclear Imaging Market by PET-Neurology ($millions) (2014-2020)
112. Australia Nuclear Imaging Market by PET-Others ($millions) (2014-2020)
113. Australia Nuclear Imaging Market by Countries ($millions) (2014-2020)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll